argenx SE (ARGX)
1053.33
-2.04
(-0.19%)
USD |
NASDAQ |
Sep 03, 16:00
1053.33
0.00 (0.00%)
After-Hours: 20:00
argenx Cash from Investing (Quarterly)
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2014 | -0.0424M |
| Date | Value |
|---|---|
| March 31, 2014 | -0.0014M |
Cash From Investing Definition
Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Autolus Therapeutics Plc | 68.03M |
| Akari Therapeutics Plc | 0.00 |
| Forte Biosciences, Inc. | -147.84M |
| Evaxion AS | -- |
| DBV Technologies SA | -0.5998M |
Cash from Investing (Quarterly) Related Metrics
| Free Cash Flow | 1.090B |
| Free Cash Flow Yield | 1.58% |